1. Home
  2. Deep Mutational Scanning of Dengue Viruses for Vaccine Development
DEPARTMENT FOR BUSINESS, ENERGY & INDUSTRIAL STRATEGY

Deep Mutational Scanning of Dengue Viruses for Vaccine Development

IATI Identifier: GB-GOV-13-FUND--Newton-MR_R020957_1
Project disclaimer
Disclaimer: The data for this page has been produced from IATI data published by DEPARTMENT FOR BUSINESS, ENERGY & INDUSTRIAL STRATEGY. Please contact them (Show Email Address) if you have any questions about their data.

Description

Emerging viral infections are a global threat to public health. Dengue is a mosquito-borne viral disease of common occurrence in most tropical and many subtropical areas. The only licensed vaccine available shows suboptimal protective efficacy especially for Dengue serotype 2. Consequently, vector control measures are the only widely used means of disease prevention and development of more potent and cross-reactive dengue vaccine would represent a major advance in disease control. Research to identify vaccines has been hampered by limitations of conventional approaches that cannot comprehensively search for useful viral mutations. The current project aims to implement an approach that combines a novel massively parallel experimental technique and a virus construction technique developed in our lab to comprehensively test dengue virus mutants for their resistance to a host immune response. This exercise will identify novel mutations that affect dengue resistance to a key antiviral pathway. It will produce a collection of dengue mutants with varying degree of host resistance, enabling us to test different levels of viral attenuation which is critical for finding optimal immune responses for developing an effective vaccine. Characterizations of these viruses by a battery of immunological and virological assays will give us an idea of the relationship between viral attenuation and the ensuing immune response, key information for fine tuning the efficacy of a dengue vaccine. Future application of this exercise to investigate multiple interactions between virus and host immunity could accelerate our path to identify the elusive correlates of protection for dengue in humans.

Objectives

The Newton Fund builds research and innovation partnerships with developing countries across the world to promote the economic development and social welfare of the partner countries.


Location

The country, countries or regions that benefit from this Programme.
Thailand
Disclaimer: Country borders do not necessarily reflect the UK Government's official position.

Status Post-completion

The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.

Programme Spend

Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.

Participating Organisation(s)

Help with participating organisations

Accountable:Organisation responsible for oversight of the activity

Extending: Organisation that manages the budget on behalf of the funding organisation.

Funding: Organisation which provides funds.

Implementing: Organisations implementing the activity.

Sectors

Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.

Budget

A comparison across financial years of forecast budget and spend to date on the Programme.

Download IATI Data for GB-GOV-13-FUND--Newton-MR_R020957_1